J I Silverberg1,2, N Patel3, S Immaneni3, B Rusniak2, N B Silverberg4, R Debashis4, N Fewkes5, E L Simpson5. 1. Departments of Dermatology, Preventive Medicine and Medical Social Sciences, Feinberg School of Medicine at Northwestern University, Chicago, IL, U.S.A. 2. Northwestern Medicine Multidisciplinary Eczema Center, Chicago, IL, U.S.A. 3. Department of Dermatology, Feinberg School of Medicine at Northwestern University, Chicago, IL, U.S.A. 4. Department of Dermatology, Mount Sinai St Luke's-Roosevelt Hospital and Beth Israel Medical Centers, New York, NY, U.S.A. 5. Department of Dermatology, Oregon Health Science University, Portland, OR, U.S.A.
Abstract
BACKGROUND: The epidemiology of atopic dermatitis (AD) in the U.S.A. has been described largely via US population-based questionnaire studies. However, the validity of the questions used for self- and caregiver-reported eczema has not been previously demonstrated. OBJECTIVES: To validate the assessment of self- and caregiver-reported eczema. METHODS: We performed a prospective multicentre dermatology-practice-based study (three sites) to determine the validity of caregiver- and self-reported ever having eczema and 1-year history of eczema. Questionnaires were administered to unselected patients prior to their encounter. Patients (n = 782) were then evaluated by expert dermatologists trained in utilizing the Hanifin and Rajka criteria for AD. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value were determined. RESULTS: Caregiver-reported 1-year history of childhood eczema was found to have a sensitivity (95% confidence interval) of 0·70 (0·59-0·80), specificity of 0·96 (0·93-0·99) and PPV of 0·87 (0·78-0·96) when compared with a physician's diagnosis of AD at that visit. Similarly, self-reported 1-year history of adult eczema was found to have a sensitivity of 0·70 (0·59-0·80), specificity of 0·95 (0·93-0·97) and PPV of 0·76 (0·64-0·85). The specificities and PPVs of a history of ever having caregiver- (0·89, 0·82-0·96 and 0·81, 0·70-0·93) and self-reported eczema (0·97, 0·95-0·99 and 0·91, 0·85-0·97) were high, with a high sensitivity in children (0·83, 0·72-0·95) but not in adults (0·43, 0·37-0·51). CONCLUSIONS: Self- and caregiver-reported diagnosis of eczema ever or in the past year based on a single question demonstrates sufficient validity for the epidemiological study of AD.
BACKGROUND: The epidemiology of atopic dermatitis (AD) in the U.S.A. has been described largely via US population-based questionnaire studies. However, the validity of the questions used for self- and caregiver-reported eczema has not been previously demonstrated. OBJECTIVES: To validate the assessment of self- and caregiver-reported eczema. METHODS: We performed a prospective multicentre dermatology-practice-based study (three sites) to determine the validity of caregiver- and self-reported ever having eczema and 1-year history of eczema. Questionnaires were administered to unselected patients prior to their encounter. Patients (n = 782) were then evaluated by expert dermatologists trained in utilizing the Hanifin and Rajka criteria for AD. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value were determined. RESULTS: Caregiver-reported 1-year history of childhood eczema was found to have a sensitivity (95% confidence interval) of 0·70 (0·59-0·80), specificity of 0·96 (0·93-0·99) and PPV of 0·87 (0·78-0·96) when compared with a physician's diagnosis of AD at that visit. Similarly, self-reported 1-year history of adult eczema was found to have a sensitivity of 0·70 (0·59-0·80), specificity of 0·95 (0·93-0·97) and PPV of 0·76 (0·64-0·85). The specificities and PPVs of a history of ever having caregiver- (0·89, 0·82-0·96 and 0·81, 0·70-0·93) and self-reported eczema (0·97, 0·95-0·99 and 0·91, 0·85-0·97) were high, with a high sensitivity in children (0·83, 0·72-0·95) but not in adults (0·43, 0·37-0·51). CONCLUSIONS: Self- and caregiver-reported diagnosis of eczema ever or in the past year based on a single question demonstrates sufficient validity for the epidemiological study of AD.
Authors: C Flohr; G Weinmayr; S K Weiland; E Addo-Yobo; I Annesi-Maesano; B Björkstén; L Bråbäck; G Büchele; M Chico; P Cooper; M Clausen; N El Sharif; A Martinez Gimeno; R S Mathur; E von Mutius; M Morales Suarez-Varela; N Pearce; V Svabe; G W K Wong; M Yu; N S Zhong; H C Williams Journal: Br J Dermatol Date: 2009-05-26 Impact factor: 9.302
Authors: Yuhree Kim; Maria Blomberg; Sheryl L Rifas-Shiman; Carlos A Camargo; Diane R Gold; Jacob P Thyssen; Augusto A Litonjua; Emily Oken; Maryam M Asgari Journal: J Invest Dermatol Date: 2018-11-08 Impact factor: 8.551
Authors: Aaron M Drucker; Eliza I Pope; Alison E Field; Abrar A Qureshi; Orianne Dumas; Carlos A Camargo Journal: J Allergy Clin Immunol Pract Date: 2018-11-08
Authors: Jonathan I Silverberg; Jing Song; Daniel Pinto; Sherry H Yu; Abigail L Gilbert; Dorothy D Dunlop; Rowland W Chang Journal: J Invest Dermatol Date: 2016-05-14 Impact factor: 8.551